Technology | June 01, 2008

Molecular Imaging Agents Created for In Vivo, In Vitro Applications

Carestream expanded its line of imaging agents with Kodak X-Sight Nanosphere Conjugates labeled with Streptavidin for both in vivo and in vitro applications, aiming to provide an effective means for life science researchers to detect biotinylated probes in fluorescent molecular biology research applications.

The new conjugates labeled with Streptavidin will be offered in four distinct wavelengths from ultraviolet (UV) to near infrared (near IR). They are designed to provide an incredibly bright platform for translating molecular imaging experiments from in vitroto in vivoapplications.

The Kodak X-Sight imaging agent family also includes KODAKX SIGHT Nanospheres and KODAKX-SIGHT Large Stokes Shift Dyes, which are also offered in a variety of conjugated forms. While the KODAKX-SIGHT Imaging Agents have been optimized for KODAK In-Vivo Imaging Systems and KODAK Image Stations, they are compatible with other commercially available digital imaging systems.

Kodak X-SightNanosphere Conjugates labeled with Streptavidin will be available in July.

Related Content

Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.

Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.

Feature | Contrast Media Injectors | April 11, 2019 | By Jeff Zagoudis
One of the most controversial issues in radiology in recent years has been the use of...
Non-Contrast MRI Effective in Monitoring MS Patients
News | Neuro Imaging | March 18, 2019
Brain magnetic resonance imaging (MRI) without contrast agent is just as effective as the contrast-enhanced approach...
Ultrasound Societies Urge FDA to Remove "Black Box" on Ultrasound Contrast Agents
News | Ultrasound Imaging | March 07, 2019
National and international ultrasound societies are urging the U.S. Food and Drug Administration to remove the “black...
Sponsored Content | Case Study | Contrast Media | January 30, 2019
The medical imaging market relies heavily on contrast media, injected into patients to increase the contrast of bodil
Sponsored Content | Videos | Contrast Media | January 22, 2019
ITN Contributing Editor Greg Freiherr speaks with Guerb
Videos | Artificial Intelligence | December 21, 2018
Enhao Gong, Ph.D., founder of Subtle Medical, an artificial intelligence (AI) company that develops products to help
Guerbet Showcases Diagnostic and Interventional Imaging Solutions at RSNA 2018
News | Interventional Radiology | December 12, 2018
Guerbet LLC USA highlighted new and next-level product offerings and partnerships in contrast media, injectors,...
Guerbet Launches Multi-Use OptiVantage Contrast Media Injector in Europe
Technology | Contrast Media Injectors | December 05, 2018
Contrast agent company Guerbet recently announced that the OptiVantage multi-use contrast media injector is now CE...
VigiLanz and Cincinnati Children's Commercialize Real-Time Acute Kidney Injury Tracking
News | Contrast Media | November 30, 2018
VigiLanz and Cincinnati Children’s Hospital Medical Center recently announced a collaboration that leverages Cincinnati...
Artificial Intelligence May Help Reduce Gadolinium Dose in MRI

Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.

News | Contrast Media | November 27, 2018
Researchers are using artificial intelligence (AI) to reduce the dose of a contrast agent that may be left behind in...